Malignant Cutaneous Neoplasms. Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP

Similar documents
Malignant Cutaneous Neoplasms

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

Clinical characteristics

Living Beyond Cancer Skin Cancer Detection and Prevention

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

Learning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating

Periocular Malignancies

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine

Skin Malignancies. Presented by Dr. Douglas Paauw

Dermatological Manifestations in the Elderly. Sanjay Siddha Staff Dermatologist UHN & MSH

Skin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry

Identifying Benign and Malignant Skin Lesions. No Disclosures. Common Benign Lesions. Benign Lesions 2/25/2018. Stucco Keratoses.

Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012

Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk.

Dermoscopy: Recognizing Top Five Common In- Office Diagnoses

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

Periocular skin cancer

Disclosures. I have no conflicts of interest to disclose

I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee

Actinic keratosis (AK): Dr Sarma s simple guide

VACAVILLE DERMATOLOGY

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

Steven Robinson. Steven Robinson Memorial Endowment at

General information about skin cancer

Pathology of the skin. 2nd Department of Pathology, Semmelweis University

Skin Cancer 101: Diagnosis and Management of the Most Common Cancer

Skin Cancer - Non-Melanoma

Disclosures. Melanoma and Non melanoma Skin Cancer: What You Need to Know. I have no conflicts of interest to disclose

LUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT

Malignant Melanoma Early Stage. A guide for patients

Melanoma: The Basics. What is a melanocyte?

SKIN CANCER. Most common cancer diagnosis 40% of all cancers

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am

See spot change: Lesion identification and management in primary care ERIN HENNESSEY DNP, APRN, FNP-C

Skin Cancer. There are many types of diseases. From a simple cold to the deadly disease

Exenteration. Introduction. The skin. Epidermal malignancies 8/3/2017. Neglected basal cell carcinoma


Case Presentation Protocol 2018 Hot Spots in Dermatology

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 13, :30 am 11:00 am

Skin Cancer Awareness

SKIN. 3. How is the skin structured around the finger joints to allow for flexible movement of the fingers?

Integumentary System

Richard Turner Consultant Dermatologist

LPN2008 l Volume 4, Number 4

Gross Appearance & Histology of Skin Cancer. Kyle Mannion M.D. January 21, 2005

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media

Skin Cancers Emerging Trends and Treatment Approaches

Dual Wavelength Phototherapy System

Oral and Maxillofacial Surgery Department

Skin Cancer of the Nose: Common and Uncommon

Skin Cancer in Organ Transplant Recipients Challenges and Opportunities

Limit Direct Sun Exposure

Basal cell carcinoma 5/28/2011

Technicians & Nurses Program

Integumentary System-Skin and Body Coverings

Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Case-Based Approach to Common Dermatologic Neoplasms

See spot change: Lesion identification and management in primary care ERIN HENNESSEY DNP, APRN, FNP-C

SKIN HISTOLOGY AND FUNCTION

Non-melanoma Skin Cancer

Lid Lesions: Relax or Refer

Have a Voice in Your Choice!

Healthy Skin Education in Alabama s Schools. Alabama Comprehensive Cancer Control Program

Sun Safety and Skin Cancer Prevention. Maryland Skin Cancer Prevention Program

Treatments used Topical including cleansers and moisturizer Oral medications:

Skin Cancer. Dr Elizabeth Ogden Associate Specialist in Dermatology East and North Herts Dr Elizabeth Ogden

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

Skin Care in Renal Transplant Patients

UV Spectrum Comprises 3 Ranges

Thursday 21 st August Skin Problems

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

Principles of Anatomy and Physiology

Describe the functions of the vertebrate integumentary system. Discuss the structure of the skin and how it relates to function.

SEBACEOUS NEOPLASMS. Dr. Prachi Saraogi Clinical Fellow in Dermatology

SQUAMOUS CELL CARCINOMA

Cutaneous Adnexal Tumors

MELANOMA. 4 Fitzroy Square, London W1T 5HQ Tel: Fax: Registered Charity No.

Basal cell carcinoma

Chapter 8 Skin Disorders and Diseases

The Sun and Your Skin

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

Review of Cutaneous Malignancies

All the Rest. What is All the Rest? Integumentary System. First are the FUNCTI0NS. THERMOREGULATION function. PROTECTION function 10/12/16

Field vs Lesional Therapies for AKs 3/2/2019, 9:00-12 AM

Pathology. Skin Tumor. Bayan N. Mohammad 15/10/2015. Mohammad al-orjani. Page 0 of 23

Talking to Your Clients About Skin Cancer. Objectives 9/9/2017. Amanda Friedrichs, MD, FAAD AMTA National Conference September 14, 2017

Doctors of Optometry Course Notes

Regression 2/3/18. Histologically regression is characterized: melanosis fibrosis combination of both. Distribution: partial or focal!

Actinic Keratoses and Bowen s disease

MELANOMA. Some people are more likely to get a m Melanoma than others:

Transcription:

Malignant Cutaneous Neoplasms Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP

Objectives: 1. Identify common cutaneous malignant neoplasms. 2. Identify the etiology, pathophysiology and treatment of common malignant cutaneous neoplasms. 3. Synthesize the information to identify common malignant cutaneous neoplasms. 4. Discuss pharmacologic management of common malignant cutaneous neoplasms.

Disclosures The speaker has no conflict of interest relevant to this topic

Actinic Keratosis AK Thick crusty, erythematous scale

Pigmented Actinic Keratosis Kathleen Haycraft

AK on forehead and associated SCC kathleenhaycraft

Etiology/Pathophysiology More likely Over 40, more common in men. Have a history of frequent or intense sun exposure or sunburn. Have pale skin, red or blond hair, and blue or light-colored eyes. Progressively lower incidence in Fitzpatrick1-5, almost nonexistent in 6. Personal history of an actinic keratosis or skin cancer.

Etiology/Pathophysiology Have a weak immune system as a result of chemotherapy, chronic leukemia, AIDS or organ transplant medications. If not treated they have a 20% chance of conversion to SCC. A skin biopsy to confirm the diagnosis and rule out invasive squamous cell carcinoma for suspicious or more advanced lesions (hyperkeratosis, increased erythema, or induration or nodularity) or if they are recurrent that did not respond to therapy. UV-induced mutations in key genes, including TP53 and deletion of the gene coding for p16 tumor suppressor protein.

Etiology/Pathophysiology Dysplasia and architectural disorder of the epidermis. Abnormal keratinocytes of the basal layer, variable in size and shape Altered cellular polarity Nuclear atypia Hyperkeratosis/parakeratosis of the epidermis Irregular acanthosis may be present In general, hair follicles, sebaceous glands, and apocrine and eccrine ducts are not involved

Be aware of the effect of the sun Nuchal Heliosis kathleenhaycraft

Even a shirt does not completely protect kathleenhaycraft

Poikiloderma of Civatte kathleenhaycraft

Sunburn kathleenhaycraft

Actinic Comedones kathleenhaycraft

Idiopathic Guttate Hypomelanosis kathleenhaycraft

Appearance Small red, brown, flesh colored, pink, or white scaly patches that do not go away. Distribution pattern on face, ears, scalp, hands, but may occur anywhere. May be numerous and coalesce. If they itch, are tender, or bleed they need to be biopsied.

Treatment Cryotherapy. Photodynamic Therapy after treatment with ALA (Levulon) that activates the light in the AK to destroy the lesion. Electrodessication and curettage. Shave biopsy to treat and assess that it has not converted. Chemical peels

Treatment Laser resurfacing. Topical agents such as 5-FU (Effudex, Carac both may increase nodular BCC), Imiquimod (Aldara, Zyclara), Picato, and diclofenac (Solaraze, Voltaren) gel, AK is a field disease and needs to be treated as such: Cryo PDT the area Cryo Topical agents.

Discuss Prevention UVA, UVB, UVC waves. Ultraviolet rays are electromagnetic radiation with a wave length less than that of visible light. UVA penetrate deeply into the dermis and subcutaneous tissue (may easily penetrate glass). UVB penetrate into the epidermis and upper dermis. UVC usually bounce off the ozone layer. UVA waves are associated with autoimmune disease.

Prevention UVA, UVB, and UVC can all damage collagen and accelerate aging UVA and UVB destroy Vitamin A in the skin further damaging collagen and accelerating photo-aging. UVA was not recognized to be as harmful but it creates many oxygen free radicals which cause further DNA damage UVA is immunosuppressive. Because UVA is not measured by most SPF testing there is no good measurement for UVA protection. According to the Skin Cancer Foundation Even if it s not hot outside, 50 to 80 percent of UV rays still burn right through the clouds. Physical barriers are more effective

Prevention UVA is immunosuppressive. Because UVA is not measured by most SPF testing there is no good measurement for UVA protection. According to the Skin Cancer Foundation Even if it s cloudy and not hot outside, 50 to 80 percent of UV rays still burn right through the clouds.

Prevention UVA waves give a quicker tan but a non-protective tan. UVB waves take about two days to begin to create a tan but the tan is protective. However, the production of melanin by UVB is called melanogenesis and direct DNA damage occurs. Melanogenesis increases the risk of cutaneous carcinoma.

Prevention Broad rimmed UV hat. Broad rimmed sunglasses. Avoid mid day sun. Wear sunscreen daily. Avobenzone, Zinc and Titanium Oxide reduce UVA. Think of the bucket theory with sunscreen.

Clinical Pearl If it is itchy or tender biopsy it. Remember that actinic keratosis is a field disease and needs to be treated as such. Nothing like MOHS on a patient with BCC or SCC that has been recurrently treated you may be there for 6 or more stages. Recent study shows if severe hypertension post PDT, likely to have BCC.

Basal Cell Cancer Crusted, ulcerated, bleeds easily

Nodular Basal Cell Cancer Slowly developed, bleeding, papule that has been there Kathleen Haycraft

BCC kathleenhaycraft

Superficial Basal Cell Cancer Pink patch of skin that has been there Kathleen Haycraft

Sensitive sites kathleenhaycraft

Etiology/Pathophysiology Most common skin cancer. Represent 90% of cutaneous carcinoma. Almost never metastasize but can cause significant local destruction. Risk factors include: low Fitzpatrick score, sun exposure, weakening of the immune system by disease or medication. 3 in 10 Caucasians will develop a BCC in their lifetime.

Appearance Appears as a small, dome shaped bump covered with telangectasias. It may appear pearl like or shiny/translucent. They are usually somewhat firm to the touch. Appear as a pimple that comes and goes or comes and stays or a patch that comes and goes or comes and stays. Are soft when you biopsy them

Types of BCC Superficial BCC Nodular BCC Pigmented BCC Cystic BCC Infiltrative BCC Morpheaform Micronodular BCC

Types of BCC Nevoid Basal Cell Carcinoma Syndrome also known as Gorlin syndrome.

Treatment Shave Biopsy to determine diagnosis but all biopsies that involve skin cancer require excision or other treatment beyond the biopsy even if margins are negative. EDCT Topical Excision

Treatment MOHS Topical Imiquimod, Picato under aluminum disc Radiation therapy PDT with photosensitizer (ALA) Hedgehog pathway inhibition

Pearls If a BCC occurs at a site where you have had recurrent cryo always MOHS. The pimple or patch that comes and goes.

Squamous Cell Cancer Crusted scale, ulcerated, rapidly developed Kathleen Haycraft

SCC kathleenhaycraft

Squamous Cell Cancer Thick scale, itchy, and slightly painful. Been there 1 year P r e v i Kathleen Haycraft

Squamous Cell Cancer Red border with yellow scale Has had kidney transplant and immune supressed Kathleen Haycraft

SCC

Cyst that ruptured BX SCC kathleenhaycraft

Cutaneous horn kathleenhaycraft

Etiology/Pathophysiology Second most common. Rarely fatal except in transplant and immune compromised patients where mortality can exceed 20%. Linked to alcohol, HPV, and tobacco as well as UV. Unlike BCC, SCC more linked to chronic rather than intense intermittent UV exposure. PUVA is a risk factor.

Etiology/Pathophysiology Histologically unique uncontrolled proliferation of squamous cells (presence of keratin, desmosomes, and/or tonofilament bundles into dermis and surrounding tissues. Squamous cell in situ the tumor has not penetrated the basement membrane. Bowens is UV induced and is an early form of SCC. Keratocanthoma is rapidly growing. One method to identify a SCC is by its appearance under the microscope.

Appearance An ulcer or plaque with scaling, ulceration, and/or crusting. Frequently on sun exposed skin. May present as a cutaneous horn (height greater than width). Peri-neural involvement is associated with pain, numbness, change in vision, or muscle twitching.

Treatment Surgical excision. MOHS EDCT on low risk lesions, low risk sites, and low risk patients. Radiation. If patients have invasive SCC, on high risk areas, in high risk patients consider imaging for metastasis first.

Pearls If the height of a cutaneous horn exceeds the width is is more apt to be benign. If more than 50 % of the base of a lesion is erythematous it is more likely to be a BCC. Immune compromised patients are at high risk for metastasis and may need imaging prior to treatment.

Melanoma New lesion, dark and asymmetric Kathleen Haycraft

Nodular Melanoma kathleenhaycraft

Melanoma When you see it with a derm-llite it is so easy Kathleen Haycraft

Lentigo Maligna Chronically UV exposed skin Peppering Changing small structures Kathleen Haycraft

Melanoma kathleenhaycraft

Melanoma kathleenhaycraft

Etiology/Pathophysiology Melanoma is a malignancy arising from the melanocyte. Less common than basal or squamous but results in 75% of the deaths from cutaneous carcinoma. Caused by damage to the DNA by UV rays. Genetic links with BRAF, MEK, CDND2A. Genetic risk is higher with associated BRCA mutations. Eumelanin is more protective than pheomelanin Interesting new alcohol link for both NMSC and MM

Appearance May appear as Asymmetric Irregular border Black, gray, blue, red, white or multiple colored lesion White veil Greater than 6 mm diameter Evolving Nodular elevated, firm, and growing.

Treatment Biopsy properly. Treatment indicated by: Breslow depth (Clark value with thin areas) Ulceration Mitotic Index Other factors Surgery, SLNB, chemotherapy, radiation, interferon, and vaccine. Lentigo maligna is a field disease.

Dysplasia, mild, moderate, severe, Clark s etc. Asymmetric It is getting bigger Irregular Border Dark Black 6mm Kathleen Haycraft

Multiple dysplastic nevi kathleenhaycraft

What do you do with this? Kathleen Haycraft

Treat the right amount kathleenhaycraft

Halo Nevus kathleenhaycraft

Etiology/Pathophysiology Atypical nevi (Dysplastic nevi). Atypical to the eye and dysplastic to the microscope. Some atypical nevi become melanoma but the majority do not. Roughly half of melanomas arise in these dysplastic nevi whereas the other half arise de novo. Melanomas can occur on sun or non-sun exposed sites.

Etiology/Pathophysiology Cytological atypia is of more significance than architectural atypia. Individuals with dysplastic nevus syndrome have an associated CDKN2A gene defect. If 5 or more, 10 times increased risk of melanoma.

Presentation ABCDE are helpful with these nevi. Ugly duckling the pretty duckling what doesn t belong with the rest. Cutaneous melanoma. Acral melanoma. Uveal melanoma.

Treatment Individuals with multiple dysplastic nevi should be monitored in a dermatology setting annually. Some dermatologists excise all, some monitor, our system is: Mild.Monitor Moderate.Excise with 2 mm margin Severe Excise with 9 mm margin

Merkel Cell Cancer Asymptomatic Pink violaceous plaques Associated telangectasias Kathleen Haycraft

Merkel Cell Cancer He was covered with these before death Kathleen Haycraft

Etiology/Pathophysiology Merkel cell carcinoma (cutaneous neuroendocrine tumor) is a malignant solid tumor derived from the Merkel cell. The Merkel cell is a mechanoreceptor that is present in the basal layer of the epidermis and surrounds the hair follicles. The tumor usually presents as a solitary lesion on the head or neck but may present as multiple lesions and on any area. The incidence of Merkel cell carcinoma (MCC) in the United States is approximately 1500 cases per year 1. As of 2005, the disease incidence had more than tripled over the previous 20 years 1.

Etiology/Pathophysiology There is an association of MCC with the polyomavirus (MCPyV). Eighty percent of MCC are infected with the virus versus 20% skin not involved with MCC. Studies confirm that MCC patients who harbor the MCPyV have a better prognosis then those who do not.

Appearance The tumor usually presents as a solitary lesion on the head or neck but may present as multiple lesions and on any area. A = Asymptomatic. E = Expanding rapidly. I = Immune suppressed. O = Older than 50 years. U = UV-exposed skin.

Appearance MCC Occurs in the elderly (greater than 65 years of age), male, immunosuppression and fair- skinned patients with chronic UV exposure. generally presents as a rapidly growing, non-tender, erythematous to violaceous nodule that has a shiny appearance. It is generally associated with overlying telangectasias.

Treatment Contrasted to melanoma with an average 5 year 15% mortality rate, MCC has a 49%. With proper staging this can increase to 79% survival rate with proper staging and treatment. There is a 4 tiered system for treatment selection that ranges from excision, SLNB, chemotherapy, radiation, or supportive care.

Mycosis Fungoides Patch Slightly pruritic Has been treated and never gets better Kathleen Haycraft

Etiology/Pathophysiology Cutaneous T-cell Lymphoma. Etiology is unclear. over 20 years of age, and it is more common in men than women. Common in sites covered with underwear. Unusual expression of CD4 T cells. May progress to Sezary syndrome 3:100,000.

Presentation Rashes, patches, or tumors that are pruritic in 20% of the cases. Frequently resembles eczema. May take many years and many biopsies to diagnose.

Treatment Depends on stage: Many never progress and rely on UVB and topical steroids. Sezary Zolinza (vorinostat) and other chemotherapies. Topical Nitrogen Mustard

References Bolognia, Jean L., Jorizzo, Josep L., & Shaffer, Julie V. (2012). Dermatology: 2-Volume Set: Expert Consult Premium Edition (3 rd ed). Philadelphia, PA: Saunders. DermNet NZ: the dermatology resource. (2013). Retrieved from http://www.dermnetnz.org/ Fitzpatrick, James E., Morelli, & Joseph G. (2011). Dermatology Secrets Plus (4th Ed ed.). Philadelphia, PA: Mosby. Habif, Thomas B. (2009). Clinical Dermatology (5th ed.). Philadelphia, PA: Mosby. Medscape Reference: Drugs, Diseases, and Procedures. (2013). Retrieved from http://reference.medscape.com/ James, William D., Berge, Timothy, & Elston, D. (2011). Andrews' Diseases of the Skin, 11th Edition (11th ed.). Philadelphia, PA: Saunders. Wolf, K., & Johnson, R. A. (2013). Fitzpatricks Color Atlas and Synopsis of Clinical Dermatology (7th Ed. ed.). Columbus OH: McGraw Hill.

Let s Have Some Fun Tired of ideas of laser and filler His face lift Kathleen Haycraft

Kathleen Haycraft

Kathleen Haycraft

Kathleen Haycraft

Kathleen Haycraft

Kathleen Haycraft

Kathleen Haycraft

Kathleen Haycraft

Kathleen Haycraft

Kathleen Haycraft

Favorite Sites Websites for patients and providers: http://www.mayoclinic.com/health/diseasesindex/diseasesindex http://emedicine.medscape.com/dermatology http://www.nlm.nih.gov/ http://www.dermnetnz.org/sitemap.html Wolf, K., & Johnson, R. A. (2013). Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology (7th Ed. ed.). Columbus OH: McGraw Hill.

Cool yet?

Thank you. Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP 300 Lovers Leap Dr Hannibal, MO 63401 kathleenhaycraft@yahoo.com 5737952808